Association of a Genetic Variant in Chromosome 9p21 with Increased Risk of Developing Cervical Cancer
Authors:
- 1 November 2023
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 19 (4) , 358-362
Abstract
Background: Cervical cancer is one of the most prevalent gynecologic cancers associated with high morbidity and mortality worldwide. There is mounting evidence indicating an association between the 9p21 locus genetic variants with susceptibility to various human malignancies. In this current study, we aimed to evaluate the potential relationship between the rs1333049 genetic variant in chromosome 9p21 and the risk of cervical carcinogenesis. Methods: The possible correlation between rs1333049 polymorphism and susceptibility to cervical cancer was investigated in 221 patients with or without cancer. DNAs were isolated and genotyped using a TaqMan-based real-time RT-PCR method. Results: The rs1333049 genetic variant was found to be correlated with an elevated risk of cervical neoplasia using recessive and additive genetic models (p < 0.001). Conclusion: Our findings indicated that the CDKN2A/B genetic variant (rs1333049) was significantly associated with an elevated risk of cancer, suggesting its potential as a novel predictive marker for cervical carcinogenesis.Keywords
Funding Information
- Mashhad University of Medical Sciences (960284, 960282)
This publication has 26 references indexed in Scilit:
- Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?Trends in Endocrinology & Metabolism, 2015
- Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancerInternational Journal of Oncology, 2015
- Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 ExpressionMolecular Cancer Therapeutics, 2015
- Genetic polymorphisms in the 9p21 region associated with risk of multiple cancersCarcinogenesis, 2014
- ANRIL: Molecular Mechanisms and Implications in Human HealthInternational Journal of Molecular Sciences, 2013
- CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMCBiochemical and Biophysical Research Communications, 2012
- Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian populationMolecular Biology Reports, 2011
- Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor geneOncogene, 2010
- Anti‐aging activity of the Ink4/Arf locusAging Cell, 2009
- Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancerCancer Letters, 2001